Navigation Links
Classical monographs re-published in advanced open access
Date:6/11/2014

Easy access to legacy data collected over hundreds-of-years of exploration of nature from the convenience of people's own computers for anyone all over the world? It may sound futuristic but a brand new pilot showcases how this is possible here and now.

The new workflow demonstrates a re-publication of a volume of Flora Malesiana in a semantically enriched HTML edition available on the newly launched, Advanced Books publishing platform. The platform was demonstrated today at the EU funded pro-iBiosphere project which supported, in part, the re-publication of Flora Malesiana.

When Linnaeus was laying the foundations of taxonomy as a science in his Species Plantarum and Systema Naturae books he probably did not imagine that his methods of publication of natural history data would remain almost unchanged for more than 270 years! The bulk of the information on the living World is still closed in paper-based legacy literature, especially in fundamental regional treatises such as Flora, Fauna and Mycota series, hardly accessible for readers, despite the dramatic changes in the publishing technologies that have taken place over the last decade.

The new pilot, developed by Pensoft Publishers in a cooperation with the Naturalis Biodiversity Center, Plazi, and Botanischer Garten und Botanisches Museum Berlin-Dahlem (BGBM), demonstrates how a fundamental book in natural history can start a new life with Advanced Books. Re-publication of the Flora of Northumberland & Durham, published in 1838, will be the next to appear as a result of a collaboration between the Botanical Garden Meise National Botanic Garden of Belgium and Pensoft.

Flora Malesiana is a systematic account of the flora of Malesia, the plant-geographical unit spanning six countries in Southeast Asia: Indonesia, Malaysia, Singapore, Brunei Darussalam, the Philippines, and Papua New Guinea. The plant treatments are not published in a systematic order but as they come about by the scientific efforts of some 100 collaborators all over the world.

With the new platform, such scientifically important historical monographs, enriched with additional information from up-to-date external sources related to organisms' names, species treatments, information on their ecology, distribution and conservation value, morphological characters, etc., become freely usable for anyone at any place in the world.

The re-publication in advanced open access comes with the many other benefits of the digitization and markup efforts such as data extraction and collation, distribution and re-use of content, archiving of different data elements in relevant repositories and so on.

"Advanced Books will bring many outstanding scientific monographs to a new life, however the platform is not only restricted to e-publish our legacy literature." commented Prof. Lyubomir Penev, Managing Director of Pensoft. "New books are mostly welcome on the platform, joining their historical predecessors in an open, common, human- and machine-readable, data space for the benefit of future researchers and the society in general" concluded Prof. Penev.


'/>"/>

Contact: Lyubomir Penev
penev@pensoft.net
Pensoft Publishers
Source:Eurekalert  

Related biology news :

1. Geniposide protects hippocampal neurons via the non-classical estrogen signaling pathway
2. Weeding out invasive species with classical biological control
3. UK invests in worlds most advanced crystallography facility
4. Phase I data suggest PLX3397 is a potential therapy for patients with advanced PVNS
5. Molecular tumor board helps in advanced cancer cases
6. Research center to develop next generation of advanced chemical products
7. Umeå University becomes national resource for advanced electron microscopy
8. Scientists invent advanced approach to identify new drug candidates from genome sequence
9. BBSRC announces £10M of funding for advanced scientific equipment
10. MU researchers develop advanced 3-dimensional force microscope
11. KaloBios Announces Preliminary Phase 1 Results in Advanced Hematologic Malignancies with KB004, an Anti-EphA3 Monoclonal Antibody
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Classical monographs re-published in advanced open access
(Date:2/13/2017)... Former 9/11 Commission border counsel and Special ... Kephart of Identity Strategy Partners, LLP, today releases ... "Executive Order: Protecting the Nation From Foreign Terrorist Entry ... "As President Trump,s ,Travel Ban, Executive Order gains more ... the travel ban, it is important that our national ...
(Date:2/8/2017)... 8, 2017 About Voice Recognition Biometrics Voice ... it against a stored voiceprint template. Acoustic features ... and tone are compared to distinguish between individual ... as most PCs already have a microphone and ... recognition biometrics are most likely to be deployed ...
(Date:2/8/2017)... , Feb. 7, 2017 The ... largely by the confluence of organizations, desires to ... for knowledge-based systems (password and challenge questions), biometrics ... and government systems. The market is driven by ... demarcation between consumer and enterprise uses cases, with ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... 2017 Kineta, Inc., a biotechnology company ... in immuno-oncology, today announced the discovery and characterization ... that activate interferon response factor 3 (IRF3) via ... tumor regression in a murine colon carcinoma mouse ... complete tumor regression to initial drug treatment were ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... solutions, today announced the hire of Dr. Sigmund “Sig” Floyd as Vice President ... strategic partnerships and joint development activities. , “Dr. Floyd’s career has spanned 30 ...
(Date:3/22/2017)... Good Start Genetics, a leading family genomics ... million covered lives mark through its most recent payor ... . With newly signed contracts nationally and others ... payor acceptance based on the quality of its science, ... its industry-leading customer care and support and its published ...
(Date:3/22/2017)... , March 22, 2017 /PRNewswire/ - FACIT ... (the "Company" or "Propellon"), a start-up created by ... anti-cancer therapeutics. FACIT,s investment, combined with non-dilutive capital, ... program. The seed funding enables Propellon to accelerate ... the Company for financing and/or entering a strategic ...
Breaking Biology Technology: